Literature DB >> 22408043

Respiratory complications after oesophagectomy for cancer do not affect disease-free survival.

Thomas D'Annoville1, Xavier Benoit D'Journo, Delphine Trousse, Geoffrey Brioude, Laetitia Dahan, Jean Francois Seitz, Christophe Doddoli, Pascal Alexandre Thomas.   

Abstract

OBJECTIVES: Recent studies have suggested that postoperative complications could have a potential negative effect on long-term outcome after oesophagectomy for cancer. Because respiratory failures represent the most frequent postoperative complication, we have investigated the prognostic impact of these complications on disease-free survival (DFS).
METHODS: From a prospective single-institution database of 405 consecutive patients who underwent transthoracic oesophagectomy for cancer, we retrospectively analysed medical charts of all patients with microscopically complete resection (R0, n = 384 patients). Complications were graded according to the modified Clavien classification. Respiratory complications were defined as atelectasis, pneumonia or acute respiratory distress syndrome in the absence of early surgical complications. Patients with grade 5 (postoperative mortality, n = 43, 11%) were excluded from the analysis. The remaining 341 patients were analysed for estimation of DFS according to the Kaplan-Meier method. Logistic regression analysis was conducted to discriminate predictive factors affecting DFS.
RESULTS: According to the modified Clavien classification, postoperative complications rates were grade 0: 147 (44%), grade 1: 7 (2%), grade 2: 56 (16%), grade 3: 69 (20%) and grade 4: 62 (18%). Five-year DFS rates were not significantly different between grade 0 (no complication, 38%, n = 147) and other grades (grade 1, 2, 3 and 4 (64, 45, 56 and 48%, respectively)). Respiratory complications occurred in 107 patients (31%) and the 5-year DFS in this subgroup was 47% compared with 38% observed in grade 0 patients (P = 0.75). Clavien classification and respiratory complications did not come out in the univariate analysis of factors affecting DFS. On logistic regression, only two variables affected DFS: c-N stage and extracapular lymph node involvement.
CONCLUSIONS: When postoperative mortality is excluded, postoperative complications do not affect DFS in patients with complete resection. This deserves substantial information regarding the prognosis of subgroup of patients in critical situations where incrementing intensive care is debated.

Entities:  

Mesh:

Year:  2012        PMID: 22408043     DOI: 10.1093/ejcts/ezs080

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

1.  Correlation of fluid balance and postoperative pulmonary complications in patients after esophagectomy for cancer.

Authors:  Xuezhong Xing; Yong Gao; Haijun Wang; Shining Qu; Chulin Huang; Hao Zhang; Hao Wang; Kelin Sun
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

2.  Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer.

Authors:  Longfei Ma; Jingpei Li; Longlong Shao; Dong Lin; Jiaqing Xiang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

3.  Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction.

Authors:  Brent T Xia; Ernest L Rosato; Karen A Chojnacki; Albert G Crawford; Benny Weksler; Adam C Berger
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

4.  Postoperative complications do not affect long-term outcome in esophageal cancer patients.

Authors:  Kirsten Lindner; Mathias Fritz; Christina Haane; Norbert Senninger; Daniel Palmes; Richard Hummel
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

5.  Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus.

Authors:  Guillaume Luc; Marlène Durand; Laurence Chiche; Denis Collet
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

6.  Predictive Factors Involved in Development of Postoperative Pulmonary Complications.

Authors:  Ayten Saraçoğlu; Ayşen Yavru; Semra Küçükgöncü; Filiz Tüzüner; Meltem Karadeniz; Burcu Başaran; Nüzhet Mert Şentürk
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-07-11

7.  The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.

Authors:  Manabu Yamamoto; Mototsugu Shimokawa; Daisuke Yoshida; Shohei Yamaguchi; Mitsuhiko Ohta; Akinori Egashira; Masahiko Ikebe; Masaru Morita; Yasushi Toh
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-17       Impact factor: 4.553

8.  Open versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma.

Authors:  Po-Kuei Hsu; Chien-Sheng Huang; Yu-Chung Wu; Teh-Ying Chou; Wen-Hu Hsu
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

9.  Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival.

Authors:  Georgios Antonios Margonis; Neda Amini; Yuhree Kim; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Douglas B Evans; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Lindsey E Moses; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

10.  The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer.

Authors:  Eisuke Booka; Hiroya Takeuchi; Tomohiko Nishi; Satoru Matsuda; Takuji Kaburagi; Kazumasa Fukuda; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Tai Omori; Yuko Kitagawa
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.